DC
IMDX

Defender Capital’s Insight Molecular Diagnostics IMDX Stock Holding History

Defender Capital’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,928
Closed -$99.4K – 25
2025
Q2 		$99.4K Sell
32,928
-11,450
-26% -$34.6K 0.03% 38
2025
Q1 		$127K Sell
44,378
-2,700
-6% -$7.3K 0.05% 34
2024
Q4 		$112K Sell
47,078
-12,275
-21% -$33.4K 0.04% 37
2024
Q3 		$169K Buy
59,353
+4,133
+7% +$12.8K 0.06% 34
2024
Q2 		$163K Sell
55,220
-665
-1% -$1.83K 0.06% 34
2024
Q1 		$164K Sell
55,885
-15,765
-22% -$48.7K 0.06% 35
2023
Q4 		$179K Sell
71,650
-42,870
-37% -$132K 0.06% 35
2023
Q3 		$357K Sell
114,520
-1,877
-2% -$6.99K 0.13% 27
2023
Q2 		$535K Sell
116,397
-1,775
-2% -$8.94K 0.18% 24
2023
Q1 		$838K Buy
118,172
+4,525
+4% +$33.6K 0.29% 19
2022
Q4 		$729K Sell
113,647
-13,952
-11% -$154K 0.29% 17
2022
Q3 		$1.88M Sell
127,599
-1,870
-1% -$32.4K 0.74% 15
2022
Q2 		$2.33M Buy
129,469
+1,362
+1% +$31K 0.91% 14
2022
Q1 		$4M Buy
128,107
+17,267
+16% +$552K 1.39% 13
2021
Q4 		$4.81M Buy
110,840
+12,799
+13% +$736K 1.54% 13
2021
Q3 		$6.93M Buy
98,041
+30,681
+46% +$2.82M 2.26% 12
2021
Q2 		$7.73M Buy
67,360
+37,137
+123% +$3.63M 2.57% 11
2021
Q1 		$3.12M Buy
+30,223
New +$2.87M 1.11% 14

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Defender Capital's IMDX Position: Q3 2025 in Review

Defender Capital sold out of Insight Molecular Diagnostics (IMDX) in Q3 2025, closing a stake of 32,928 shares — an estimated $99.4K sold.

Defender Capital first reported a position in IMDX in Q1 2021 and held it in 18 quarters. The position peaked at $7.73M in Q2 2021. 27 funds tracked by Wall St. Rank hold IMDX as of Q3 2025.

  • Defender Capital reported no remaining Insight Molecular Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Defender Capital sold 32,928 Insight Molecular Diagnostics shares in Q3 2025, an estimated $99.4K.
  • Defender Capital first reported a position in Insight Molecular Diagnostics in Q1 2021 and held it in 18 quarters.
  • Defender Capital's Insight Molecular Diagnostics position peaked at $7.73M in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q3 2025.

Based on Defender Capital's 13F filing for Q3 2025, filed 29 Oct 2025.